Literature DB >> 18015333

Typhoid Vaccine Studies: Revaccination and Duration of Immunity.

D Longfellow, G F Luippold.   

Abstract

Year:  1940        PMID: 18015333      PMCID: PMC1530973          DOI: 10.2105/ajph.30.11.1311

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN: 0002-9572


× No keyword cloud information.
  4 in total

1.  EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE.

Authors:  C P Miller
Journal:  Science       Date:  1933-10-13       Impact factor: 47.728

2.  The Effectiveness of Vaccines Used for the Prevention of Typhoid Fever in the United States Army and Navy.

Authors:  P R Hawley; J S Simmons
Journal:  Am J Public Health Nations Health       Date:  1934-07

3.  Typhoid Vaccine Studies: Investigation of Virulence and Antigenic Properties of Selected Strains of the Typhoid Organism.

Authors:  J F Siler
Journal:  Am J Public Health Nations Health       Date:  1936-03

4.  Duration of Immunity Conferred by Typhoid Vaccine: Results of Re-vaccination by Intracutaneous Injection of Typhoid Vaccine.

Authors:  J F Siler; G C Dunham
Journal:  Am J Public Health Nations Health       Date:  1939-02
  4 in total
  5 in total

1.  INTRADERMAL TAB IMMUNIZATION AGAINST ENTERIC INFECTIONS.

Authors:  P N BARDHAN; H N DUTTA; P KRISHNASWAMI
Journal:  J Hyg (Lond)       Date:  1963-09

2.  Typhoid Vaccine Studies VII: Typhoid-Paratyphoid Vaccine.

Authors:  D Longfellow; G F Luippold
Journal:  Am J Public Health Nations Health       Date:  1943-05

3.  Typhoid Vaccine Studies IX. Intracutaneous versus Subcutaneous Vaccination for Initial Immunization.

Authors:  G F Luippold
Journal:  Am J Public Health Nations Health       Date:  1944-11

4.  Immunization of man with typhoid and cholera vaccine. Agglutinating antibodies after intracutaneous and subcutaneous injection.

Authors:  H A Clasener
Journal:  J Hyg (Lond)       Date:  1967-12

Review 5.  On vaccines and vaccination: typhoid-paratyphoid fevers.

Authors:  W Vella
Journal:  Postgrad Med J       Date:  1972-02       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.